CTKB vs. SMH
CTKB (Cytek Biosciences, Inc.) is a stock, while SMH (VanEck Semiconductor ETF) is Semiconductors fund tracking the MVIS US Listed Semiconductor 25 Index. Over the past 5 years, CTKB returned -28.24%/yr vs 33.46%/yr for SMH. Their 0.31 correlation means their historical movements had little consistent relationship.
Performance
CTKB vs. SMH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CTKB achieves a -16.44% return, which is significantly lower than SMH's 50.09% return.
CTKB
- 1D
- -2.09%
- 1M
- -8.06%
- 6M
- -15.60%
- YTD
- -16.44%
- 1Y
- 15.93%
- 3Y*
- -22.02%
- 5Y*
- -28.24%
- 10Y*
- —
- ALL TIME*
- -26.72%
SMH
- 1D
- 0.30%
- 1M
- -8.74%
- 6M
- 33.97%
- YTD
- 50.09%
- 1Y
- 90.95%
- 3Y*
- 50.56%
- 5Y*
- 33.46%
- 10Y*
- 34.16%
- ALL TIME*
- 11.06%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $2.86M | $3.48M | $5.70M | |
| $8.28B | $7.64B | $7.07B |
CTKB vs. SMH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
CTKB Cytek Biosciences, Inc. | -16.44% | -22.19% | -28.84% | -10.68% | -37.44% | -18.81% |
SMH VanEck Semiconductor ETF | 50.09% | 49.17% | 39.10% | 73.38% | -33.53% | 21.53% |
Correlation
The correlation between CTKB and SMH is 0.19, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.19 |
Correlation (3Y) Balances recent behavior with more history. | 0.21 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.30 |
Correlation (All Time) Calculated using the full available price history since Jul 23, 2021 | 0.31 |
The correlation between CTKB and SMH shifts across timeframes, from 0.19 (1 year) to 0.31 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CTKB vs. SMH — Risk / Return Rank
CTKB
SMH
CTKB vs. SMH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Cytek Biosciences, Inc. (CTKB) and VanEck Semiconductor ETF (SMH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CTKB | SMH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.99 | ||
| Sortino ratioReturn per unit of downside risk | -1.83 | ||
| Omega ratioGain probability vs. loss probability | 1.10 | 1.36 | -0.25 |
| Calmar ratioReturn relative to maximum drawdown | 0.40 | 3.58 | -3.18 |
| Martin ratioReturn relative to average drawdown | 0.88 | 14.64 | -13.77 |
Loading charts...
Drawdowns
CTKB vs. SMH - Drawdown Comparison
The maximum CTKB drawdown since its inception was -91.34%, which is greater than SMH's maximum drawdown of -84.96%. Use the drawdown chart below to compare losses from any high point for CTKB and SMH.
Loading charts...
Drawdown Indicators
| CTKB | SMH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -91.34% | -84.96% | -6.38% |
Max Drawdown (1Y)Largest decline over 1 year | -42.94% | -24.62% | -18.32% |
Max Drawdown (3Y)Largest decline over 3 years | -74.55% | -35.74% | -38.81% |
Max Drawdown (5Y)Largest decline over 5 years | -91.34% | -45.30% | -46.04% |
Max Drawdown (10Y)Largest decline over 10 years | — | -45.30% | — |
Current DrawdownCurrent decline from peak | -84.89% | -19.19% | -65.70% |
Average DrawdownAverage peak-to-trough decline | -68.38% | -40.89% | -27.49% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 19.70% | 6.01% | +13.69% |
Volatility
CTKB vs. SMH - Volatility Comparison
The current volatility for Cytek Biosciences, Inc. (CTKB) is 8.27%, while VanEck Semiconductor ETF (SMH) has a volatility of 14.70%. This indicates that CTKB experiences smaller price fluctuations and is considered to be less risky than SMH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CTKB | SMH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.27% | 14.70% | -6.43% |
Volatility (6M)Calculated over the trailing 6-month period | 35.30% | 33.13% | +2.17% |
Volatility (1Y)Calculated over the trailing 1-year period | 56.57% | 38.57% | +18.00% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 64.84% | 36.50% | +28.34% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 65.22% | 33.32% | +31.90% |
Dividends
CTKB vs. SMH - Dividend Comparison
CTKB has not paid dividends to shareholders, while SMH's dividend yield for the trailing twelve months is around 0.20%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CTKB Cytek Biosciences, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SMH VanEck Semiconductor ETF | 0.20% | 0.31% | 0.44% | 0.60% | 1.18% | 0.51% | 0.69% | 1.50% | 1.88% | 1.43% | 0.80% | 2.14% |
Frequently Asked Questions
CTKB and SMH have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SMH has higher volatility (14.70%) compared to CTKB (8.27%). In terms of maximum drawdown, CTKB dropped -91.34% vs SMH's -84.96%.
SMH currently has the higher Sharpe Ratio (2.29 vs 0.31), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CTKB and SMH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer